Geode Capital Management LLC Sells 15,298 Shares of Pediatrix Medical Group, Inc. $MD

Geode Capital Management LLC reduced its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 0.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,998,830 shares of the company’s stock after selling 15,298 shares during the period. Geode Capital Management LLC owned approximately 2.33% of Pediatrix Medical Group worth $28,687,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Allianz Asset Management GmbH grew its position in shares of Pediatrix Medical Group by 159.1% during the second quarter. Allianz Asset Management GmbH now owns 61,412 shares of the company’s stock valued at $881,000 after purchasing an additional 37,712 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of Pediatrix Medical Group by 2.9% during the first quarter. Russell Investments Group Ltd. now owns 219,184 shares of the company’s stock worth $3,176,000 after purchasing an additional 6,127 shares during the last quarter. Strs Ohio bought a new stake in shares of Pediatrix Medical Group during the first quarter worth $690,000. Counterpoint Mutual Funds LLC purchased a new stake in shares of Pediatrix Medical Group during the second quarter valued at $755,000. Finally, Wakefield Asset Management LLLP bought a new position in shares of Pediatrix Medical Group in the second quarter worth about $1,002,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Tuesday. Leerink Partners raised their target price on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Zacks Research upgraded Pediatrix Medical Group from a “hold” rating to a “strong-buy” rating in a report on Friday, November 21st. Wall Street Zen raised Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 4th. Finally, Truist Financial lifted their target price on Pediatrix Medical Group from $17.00 to $24.00 and gave the company a “hold” rating in a research report on Monday, November 10th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $21.00.

Insider Transactions at Pediatrix Medical Group

In other news, Director Laura A. Linynsky sold 10,000 shares of the firm’s stock in a transaction dated Thursday, November 6th. The shares were sold at an average price of $21.65, for a total value of $216,500.00. Following the sale, the director directly owned 32,232 shares in the company, valued at approximately $697,822.80. This trade represents a 23.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael A. Rucker sold 10,478 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $23.00, for a total transaction of $240,994.00. Following the transaction, the director owned 59,101 shares of the company’s stock, valued at approximately $1,359,323. This trade represents a 15.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.90% of the stock is owned by company insiders.

Pediatrix Medical Group Price Performance

NYSE MD opened at $23.97 on Friday. The company has a market cap of $2.06 billion, a PE ratio of 18.58 and a beta of 1.20. The firm’s 50 day moving average price is $19.27 and its 200-day moving average price is $16.17. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. Pediatrix Medical Group, Inc. has a 52-week low of $11.84 and a 52-week high of $24.99.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.21. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The business had revenue of $492.88 million for the quarter, compared to analysts’ expectations of $476.45 million. During the same quarter last year, the firm earned $0.44 EPS. The business’s revenue for the quarter was down 3.6% on a year-over-year basis. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.